Clinical aspects of aplastic anemia (Q41689620)

7 October 2017

1 reference

title

Clinical aspects of aplastic anemia (English)

1 reference

7 October 2017

Guinan EC

1 reference

7 October 2017

publication date

1 December 1997

1 reference

Hematology / Oncology Clinics of North America

7 October 2017

published in

1 reference

7 October 2017

1 reference

7 October 2017

1 reference

7 October 2017

page(s)

1025-1044

1 reference

Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty "untransfused" patients

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Aplastic anaemia: Evidence for an immunological mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: a randomized trial from the EBMT SAA working party

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Epstein-Barr virus in the bone marrow of patients with aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Comparison between bone marrow transplantation and antithymocyte globulin in treatment of young patients with severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Congenital anaemia after transplacental B19 parvovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Hepatitis-associated aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Bone marrow transplantation for severe aplastic anemia in children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Aplastic anemia after liver transplantation for fulminant liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Bone marrow transplantation from identical twins in the treatment of aplastic anaemia: implication for the pathogenesis of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Positional cloning of the Fanconi anaemia group A gene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Recombinant granulocyte-macrophage colony stimulating factor followed by immunosuppressive therapy for aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

First report of a B cell lymphoproliferative disorder arising in a patient treated with immune suppressants for severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Bone marrow transplantation for severe aplastic anemia using a phenotypically HLA-identical, SB-compatible unrelated donor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Effect of Antilymphocyte Globulin on Granulocyte Precursors in Aplastic Anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Treatment of aplastic anaemia with antilymphocyte globulin (ALG)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Graft rejection after syngeneic bone marrow transplantation for aplastic anaemia: significance of coculture studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Effect of interleukin-3 on responsiveness to granulocyte-colony-stimulating factor in severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Results of immunosuppression in 170 cases of severe aplastic anaemia. Report of the European Group of Bone Marrow Transplant (EGBMT).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Transformation of severe aplastic anemia into acute myeloblastic leukemia with monosomy 7

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Coincidence of severe aplastic anaemia with multiple sclerosis or thyroid disorders. Report of 5 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Oral cyclosporin-A is effective treatment for untreated and also for previously immunosuppressed patients with severe bone marrow failure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Assay of an activity in the serum of patients with disorders of thrombopoiesis that stimulates formation of megakaryocytic colonies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Suppression of erythroid-colony formation by lymphocytes from patients with aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Long-term granulocyte-macrophage colony-stimulating factor and immunosuppression in the treatment of acquired severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Predictive factors for response to anti-thymocyte globulin in acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Myelodysplasia and acute myeloid leukaemia in cases of aplastic anaemia and congenital neutropenia following G-CSF administration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Fatal aplastic anemia caused by Epstein-Barr virus infection after autologous bone marrow transplantation for non-Hodgkin malignant lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Cyclosporin A in the treatment of severe acute aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Myelodysplasia following aplastic anaemia-paroxysmal nocturnal haemoglobinuria syndrome after treatment with immunosuppression and G-CSF: evidence for the emergence of a separate clone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Myelodysplasia and leukemia after treatment of aplastic anemia with G-CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Very low doses of GM-CSF administered alone or with erythropoietin in a plastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Phase I study of recombinant human interleukin-3 in patients with bone marrow failure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

In vitro interferon-gamma production by cultured T-cells in severe aplastic anaemia: correlation with granulomonopoietic inhibition in patients who respond to anti-thymocyte globulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

A prospective clinical and immunologic analysis of patients with serum sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

COURSE AND PROGNOSIS IN APLASTIC ANAEMIA.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Changes in peripheral blood mononuclear cell subpopulations during antithymocyte globulin therapy for severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Phenotypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

In vitro assessment of marrow ‘stem cell’and stromal cell function in aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Avascular necrosis after treatment of aplastic anaemia with antilymphocyte globulin and high-dose methylprednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Bone Marrow Graft in Man after Conditioning by Antilymphocytic Serum

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Bone marrow in leukemia and aplastic anemia: MR imaging before, during, and after treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Antithymocyte globulin treatment of severe aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Long-term follow-up in patients with aplastic anemia. A study of 137 androgen-treated patients surviving more than two years. Joint Group for the Study of Aplastic and Refractory Anemias

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Cyclosporine A in five children with severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Acquired aplastic anaemia: a PNH-like disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

gamma-Interferon gene expression in the bone marrow of patients with aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Magnetic resonance imaging of the bone marrow in patients with leukemia, aplastic anemia, and lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Analysis of c-kit gene integrity in aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Secondary solid malignant tumors occurring after bone marrow transplantation for severe aplastic anemia given thoraco-abdominal irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Hematologic bone marrow disorders: quantitative chemical shift MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

A phase I/II trial of recombinant human interleukin-6 in patients with aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Immunosuppression prior to marrow transplantation for sensitized aplastic anemia patients: comparison of TLI with TBI.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Recovery From Aplastic Anemia After Treatment With Antilymphocyte Globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Short-term study of chimaerism after bone marrow transplantation for severe aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Bilineage response in refractory aplastic anemia patients following long-term administration of recombinant human granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Cloning of cDNAs for Fanconi's anaemia by functional complementation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Cyclosporine in refractory severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Late haematological complications in severe aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Clonal haematopoiesis in children with acquired aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Clinical Course in 28 Unselected Patients with Aplastic Anaemia Treated with Anabolic Steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

A trial of recombinant human interleukin-1 in patients with severe refractory aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

Circulating activated suppressor T lymphocytes in aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970481-0

7 January 2021

10.1016/S0889-8588(05)70481-0

Identifiers

DOI

1 reference

7 October 2017

1 reference